|
2014-05-16 |
2014-05-16 |
V
Vente
|
OCAMPO CHRISTINE
Vice President, Finance
Dirigeant
|
11 900
-79.9%
4,88
58 072 USD
|
11 900
-79.9%
|
4,88
|
58 072 USD
|
|
|
2013-12-19 |
2013-12-17 |
A
Achat
|
PALEKAR ROHAN
SVP & Chief Commercial Officer
Dirigeant
|
10 000
+7.5%
2,80
28 000 USD
|
10 000
+7.5%
|
2,80
|
28 000 USD
|
|
|
2013-11-05 |
2013-11-04 |
A
Achat
|
PALEKAR ROHAN
SVP & Chief Commercial Officer
Dirigeant
|
10 000
+8.1%
4,19
41 895 USD
|
10 000
+8.1%
|
4,19
|
41 895 USD
|
|
|
2012-05-14 |
2012-05-10 |
A
Achat
|
Siffert Joao MD
SVP, R&D
Dirigeant
|
2 700
+9.2%
2,96
7 992 USD
|
2 700
+9.2%
|
2,96
|
7 992 USD
|
|
|
2012-03-07 |
2012-03-06 |
A
Achat
|
MATHEWS CHARLES
Administrateur non-exécutif
|
5 000
+inf%
2,69
13 473 USD
|
5 000
+inf%
|
2,69
|
13 473 USD
|
|
|
2012-03-07 |
2012-03-06 |
A
Achat
|
OCAMPO CHRISTINE
Vice President, Finance
Dirigeant
|
3 000
+inf%
2,60
7 795 USD
|
3 000
+inf%
|
2,60
|
7 795 USD
|
|
|
2010-11-10 |
2010-11-09 |
V
Vente
|
Clarus Lifesciences I, L.P.
Actionnaire important
|
1 200 000
-15.2%
4,81
5 773 920 USD
|
1 200 000
-15.2%
|
4,81
|
5 773 920 USD
|
|
|
2010-11-10 |
2010-11-08 |
V
Vente
|
Clarus Lifesciences I, L.P.
Actionnaire important
|
44 626
-0.6%
5,10
227 593 USD
|
44 626
-0.6%
|
5,10
|
227 593 USD
|
|
|
2010-11-05 |
2010-11-05 |
V
Vente
|
Clarus Lifesciences I, L.P.
Actionnaire important
|
332 572
-4.0%
4,80
1 597 377 USD
|
332 572
-4.0%
|
4,80
|
1 597 377 USD
|
|
|
2010-11-05 |
2010-11-03 |
V
Vente
|
Clarus Lifesciences I, L.P.
Actionnaire important
|
1 400 106
-14.5%
4,52
6 332 539 USD
|
1 400 106
-14.5%
|
4,52
|
6 332 539 USD
|
|
|
2010-11-02 |
2010-11-02 |
V
Vente
|
Clarus Lifesciences I, L.P.
Actionnaire important
|
1 290 871
-11.8%
4,49
5 800 400 USD
|
1 290 871
-11.8%
|
4,49
|
5 800 400 USD
|
|
|
2010-11-02 |
2010-11-01 |
V
Vente
|
Clarus Lifesciences I, L.P.
Actionnaire important
|
2 478 142
-18.5%
5,36
13 273 424 USD
|
2 478 142
-18.5%
|
5,36
|
13 273 424 USD
|
|
|
2010-11-02 |
2010-10-29 |
V
Vente
|
Clarus Lifesciences I, L.P.
Actionnaire important
|
1 424 947
-9.6%
5,06
7 215 647 USD
|
1 424 947
-9.6%
|
5,06
|
7 215 647 USD
|
|
|
2010-10-12 |
2010-10-11 |
V
Vente
|
Clarus Lifesciences I, L.P.
Actionnaire important
|
311 000
-2.1%
3,52
1 093 445 USD
|
311 000
-2.1%
|
3,52
|
1 093 445 USD
|
|
|
2010-10-12 |
2010-10-08 |
V
Vente
|
Clarus Lifesciences I, L.P.
Actionnaire important
|
240 838
-1.6%
3,47
836 792 USD
|
240 838
-1.6%
|
3,47
|
836 792 USD
|
|
|
2010-07-15 |
2010-07-13 |
V
Vente
|
Clarus Lifesciences I, L.P.
Actionnaire important
|
165 000
-1.1%
3,53
583 143 USD
|
165 000
-1.1%
|
3,53
|
583 143 USD
|
|
|
2009-10-13 |
2009-10-13 |
V
Vente
|
Moorin Jay
Actionnaire important
|
547 135
-7.1%
2,23
1 220 111 USD
|
547 135
-7.1%
|
2,23
|
1 220 111 USD
|
|
|
2009-10-13 |
2009-10-12 |
V
Vente
|
Moorin Jay
Actionnaire important
|
427 145
-5.3%
2,12
905 547 USD
|
427 145
-5.3%
|
2,12
|
905 547 USD
|
|
|
2009-10-13 |
2009-10-09 |
V
Vente
|
Moorin Jay
Actionnaire important
|
804 712
-9.0%
2,46
1 979 592 USD
|
804 712
-9.0%
|
2,46
|
1 979 592 USD
|
|
|
2009-08-13 |
2009-08-11 |
V
Vente
|
Vivo Ventures Fund VI, L.P.
Actionnaire important
|
232 450
-2.8%
3,37
783 938 USD
|
232 450
-2.8%
|
3,37
|
783 938 USD
|
|
|
2009-08-13 |
2009-08-11 |
V
Vente
|
Moorin Jay
Actionnaire important
|
894 120
-9.1%
3,58
3 200 950 USD
|
894 120
-9.1%
|
3,58
|
3 200 950 USD
|
|
|
2009-08-13 |
2009-08-11 |
V
Vente
|
Vivo Ventures Fund VI, L.P.
Actionnaire important
|
49 800
-0.6%
4,05
201 690 USD
|
49 800
-0.6%
|
4,05
|
201 690 USD
|
|
|
2009-08-03 |
2009-07-31 |
V
Vente
|
Vivo Ventures Fund VI, L.P.
Actionnaire important
|
1 400
-0.0%
2,20
3 080 USD
|
1 400
-0.0%
|
2,20
|
3 080 USD
|
|
|
2009-08-03 |
2009-07-30 |
V
Vente
|
Vivo Ventures Fund VI, L.P.
Actionnaire important
|
142 366
-1.7%
2,29
326 445 USD
|
142 366
-1.7%
|
2,29
|
326 445 USD
|
|
|
2009-08-03 |
2009-07-29 |
V
Vente
|
Vivo Ventures Fund VI, L.P.
Actionnaire important
|
145 500
-1.7%
2,28
331 245 USD
|
145 500
-1.7%
|
2,28
|
331 245 USD
|
|
|
2009-08-03 |
2009-07-28 |
V
Vente
|
Vivo Ventures Fund VI, L.P.
Actionnaire important
|
122 100
-1.4%
2,42
295 714 USD
|
122 100
-1.4%
|
2,42
|
295 714 USD
|
|
|
2008-10-24 |
2008-10-22 |
A
Achat
|
Moorin Jay
Actionnaire important
|
10 600
+0.1%
0,48
5 088 USD
|
10 600
+0.1%
|
0,48
|
5 088 USD
|
|
|
2008-10-15 |
2008-10-15 |
A
Achat
|
Moorin Jay
Actionnaire important
|
6 465
+0.1%
0,49
3 168 USD
|
6 465
+0.1%
|
0,49
|
3 168 USD
|
|
|
2008-10-15 |
2008-10-14 |
A
Achat
|
Moorin Jay
Actionnaire important
|
32 300
+0.3%
0,50
16 150 USD
|
32 300
+0.3%
|
0,50
|
16 150 USD
|
|
|
2008-10-15 |
2008-10-10 |
A
Achat
|
Moorin Jay
Actionnaire important
|
73 551
+0.8%
0,45
33 098 USD
|
73 551
+0.8%
|
0,45
|
33 098 USD
|
|
|
2008-10-10 |
2008-10-09 |
A
Achat
|
Moorin Jay
Actionnaire important
|
41 385
+0.4%
0,48
19 865 USD
|
41 385
+0.4%
|
0,48
|
19 865 USD
|
|
|
2008-10-10 |
2008-10-08 |
A
Achat
|
Moorin Jay
Actionnaire important
|
114 384
+1.2%
0,50
57 192 USD
|
114 384
+1.2%
|
0,50
|
57 192 USD
|
|
|
2008-10-10 |
2008-10-07 |
A
Achat
|
Moorin Jay
Actionnaire important
|
21 318
+0.2%
0,48
10 233 USD
|
21 318
+0.2%
|
0,48
|
10 233 USD
|
|
|
2008-09-17 |
2008-09-17 |
A
Achat
|
Moorin Jay
Actionnaire important
|
413 217
+4.5%
0,80
330 574 USD
|
413 217
+4.5%
|
0,80
|
330 574 USD
|
|
|
2008-09-17 |
2008-09-16 |
A
Achat
|
Moorin Jay
Actionnaire important
|
17 387
+0.2%
0,76
13 214 USD
|
17 387
+0.2%
|
0,76
|
13 214 USD
|
|
|
2008-09-17 |
2008-09-15 |
A
Achat
|
Moorin Jay
Actionnaire important
|
244 449
+2.8%
0,85
207 782 USD
|
244 449
+2.8%
|
0,85
|
207 782 USD
|
|
|
2008-09-10 |
2008-09-10 |
A
Achat
|
Moorin Jay
Actionnaire important
|
48 103
+0.5%
0,91
43 774 USD
|
48 103
+0.5%
|
0,91
|
43 774 USD
|
|
|
2008-09-10 |
2008-09-09 |
A
Achat
|
Moorin Jay
Actionnaire important
|
146 400
+1.7%
0,92
134 688 USD
|
146 400
+1.7%
|
0,92
|
134 688 USD
|
|
|
2008-09-10 |
2008-09-08 |
A
Achat
|
Moorin Jay
Actionnaire important
|
125 000
+1.5%
0,95
118 750 USD
|
125 000
+1.5%
|
0,95
|
118 750 USD
|
|
|
2008-09-04 |
2008-09-04 |
A
Achat
|
Moorin Jay
Actionnaire important
|
52 113
+0.6%
0,95
49 507 USD
|
52 113
+0.6%
|
0,95
|
49 507 USD
|
|
|
2008-09-04 |
2008-09-03 |
A
Achat
|
Moorin Jay
Actionnaire important
|
6 864
+0.1%
0,93
6 384 USD
|
6 864
+0.1%
|
0,93
|
6 384 USD
|
|
|
2008-09-04 |
2008-09-02 |
A
Achat
|
Moorin Jay
Actionnaire important
|
323 550
+4.0%
0,93
300 902 USD
|
323 550
+4.0%
|
0,93
|
300 902 USD
|
|
|
2008-08-29 |
2008-08-27 |
A
Achat
|
Moorin Jay
Actionnaire important
|
89 447
+1.1%
0,95
84 975 USD
|
89 447
+1.1%
|
0,95
|
84 975 USD
|
|
|
2008-08-18 |
2008-08-15 |
A
Achat
|
Moorin Jay
Actionnaire important
|
114 032
+1.4%
0,95
108 330 USD
|
114 032
+1.4%
|
0,95
|
108 330 USD
|
|
|
2008-08-18 |
2008-08-14 |
A
Achat
|
Moorin Jay
Actionnaire important
|
6 051
+0.1%
0,90
5 446 USD
|
6 051
+0.1%
|
0,90
|
5 446 USD
|
|
|
2008-08-08 |
2008-08-07 |
A
Achat
|
Moorin Jay
Actionnaire important
|
91 380
+1.2%
0,98
89 552 USD
|
91 380
+1.2%
|
0,98
|
89 552 USD
|
|
|
2008-08-08 |
2008-08-06 |
A
Achat
|
Moorin Jay
Actionnaire important
|
400
+0.0%
0,90
360 USD
|
400
+0.0%
|
0,90
|
360 USD
|
|
|
2006-06-07 |
2006-05-31 |
V
Vente
|
SILVERSTEIN JONATHAN
Administrateur non-exécutif
|
629 121
-26.9%
9,79
6 159 095 USD
|
629 121
-26.9%
|
9,79
|
6 159 095 USD
|
|
|
2006-06-02 |
2006-05-31 |
A
Achat
|
Podlesak Dennis
Administrateur non-exécutif
|
200
+2.8%
9,91
1 982 USD
|
200
+2.8%
|
9,91
|
1 982 USD
|
|
|
2006-06-02 |
2006-05-31 |
V
Vente
|
ORBIMED ADVISORS LLC
Administrateur non-exécutif
|
629 121
-26.9%
9,79
6 159 095 USD
|
629 121
-26.9%
|
9,79
|
6 159 095 USD
|
|
|
2006-06-02 |
2006-05-31 |
A
Achat
|
Podlesak Dennis
Administrateur non-exécutif
|
800
+12.4%
9,90
7 920 USD
|
800
+12.4%
|
9,90
|
7 920 USD
|
|
|
2006-05-26 |
2006-05-26 |
A
Achat
|
Kaye Randall
VP of Medical Affairs
Dirigeant
|
250
+inf%
9,90
2 475 USD
|
250
+inf%
|
9,90
|
2 475 USD
|
|
|
2006-05-26 |
2006-05-26 |
A
Achat
|
Kaye Randall
VP of Medical Affairs
Dirigeant
|
200
+400.0%
9,90
1 980 USD
|
200
+400.0%
|
9,90
|
1 980 USD
|
|
|
2006-05-26 |
2006-05-26 |
A
Achat
|
Kaye Randall
VP of Medical Affairs
Dirigeant
|
50
+inf%
9,89
495 USD
|
50
+inf%
|
9,89
|
495 USD
|
|
|
2006-05-26 |
2006-05-26 |
A
Achat
|
HANSON GREGORY P
Vice President, CAO
Dirigeant
|
100
+2.0%
9,68
968 USD
|
100
+2.0%
|
9,68
|
968 USD
|
|
|
2006-05-26 |
2006-05-26 |
A
Achat
|
HANSON GREGORY P
Vice President, CAO
Dirigeant
|
100
+2.0%
9,67
967 USD
|
100
+2.0%
|
9,67
|
967 USD
|
|
|
2006-05-26 |
2006-05-26 |
A
Achat
|
HANSON GREGORY P
Vice President, CAO
Dirigeant
|
300
+6.4%
9,69
2 907 USD
|
300
+6.4%
|
9,69
|
2 907 USD
|
|
|
2006-05-26 |
2006-05-26 |
A
Achat
|
Kaye Randall
VP of Medical Affairs
Dirigeant
|
2 000
+inf%
10,14
20 280 USD
|
2 000
+inf%
|
10,14
|
20 280 USD
|
|
|
2006-05-26 |
2006-05-26 |
A
Achat
|
HANSON GREGORY P
Vice President, CAO
Dirigeant
|
600
+14.8%
9,65
5 790 USD
|
600
+14.8%
|
9,65
|
5 790 USD
|
|
|
2006-05-25 |
2006-05-25 |
A
Achat
|
BRANDT ERIC
President, CEO & Director
Administrateur exécutif
|
89
+0.0%
8,96
797 USD
|
89
+0.0%
|
8,96
|
797 USD
|
|
|
2006-05-25 |
2006-05-25 |
A
Achat
|
BRANDT ERIC
President, CEO & Director
Administrateur exécutif
|
2 911
+1.1%
8,97
26 112 USD
|
2 911
+1.1%
|
8,97
|
26 112 USD
|
|
|
2006-05-25 |
2006-05-25 |
A
Achat
|
BRANDT ERIC
President, CEO & Director
Administrateur exécutif
|
1 700
+0.7%
8,99
15 283 USD
|
1 700
+0.7%
|
8,99
|
15 283 USD
|
|
|
2006-05-25 |
2006-05-25 |
A
Achat
|
PUNTORIERO MICHAEL J
Senior VP, Finance, CFO
Dirigeant
|
2 500
+44.4%
9,00
22 500 USD
|
2 500
+44.4%
|
9,00
|
22 500 USD
|
|
|
2006-05-25 |
2006-05-25 |
A
Achat
|
Katkin Keith
Sr. V.P. of Sales & Marketing
Dirigeant
|
1 700
+212.5%
9,00
15 300 USD
|
1 700
+212.5%
|
9,00
|
15 300 USD
|
|
|
2006-05-25 |
2006-05-25 |
A
Achat
|
BRANDT ERIC
President, CEO & Director
Administrateur exécutif
|
6 300
+2.5%
9,00
56 700 USD
|
6 300
+2.5%
|
9,00
|
56 700 USD
|
|
|
2006-05-25 |
2006-05-25 |
A
Achat
|
EMANUELE ROBERT MARTIN
V P, Business Development
Dirigeant
|
1 000
+inf%
8,99
8 990 USD
|
1 000
+inf%
|
8,99
|
8 990 USD
|
|
|
2006-05-25 |
2006-05-25 |
A
Achat
|
PUNTORIERO MICHAEL J
Senior VP, Finance, CFO
Dirigeant
|
5 000
+800.0%
9,05
45 250 USD
|
5 000
+800.0%
|
9,05
|
45 250 USD
|
|
|
2006-05-25 |
2006-05-25 |
A
Achat
|
Katkin Keith
Sr. V.P. of Sales & Marketing
Dirigeant
|
800
+inf%
8,98
7 184 USD
|
800
+inf%
|
8,98
|
7 184 USD
|
|
|
2006-02-22 |
2006-02-17 |
V
Vente
|
SIRCAR JAGADISH C
VP of Drug Discovery
Dirigeant
|
3 600
-22.2%
16,82
60 552 USD
|
3 600
-22.2%
|
16,82
|
60 552 USD
|
|
|
2006-02-15 |
2006-02-14 |
A
Achat
|
Mazzo David J
Administrateur non-exécutif
|
1 000
+15.5%
15,59
15 590 USD
|
1 000
+15.5%
|
15,59
|
15 590 USD
|
|
|
2005-10-24 |
2005-10-20 |
A
Achat
|
SILVERSTEIN JONATHAN
Administrateur non-exécutif
|
566 038
+6.5%
2,65
1 500 001 USD
|
566 038
+6.5%
|
2,65
|
1 500 001 USD
|
|
|
2005-04-12 |
2005-04-08 |
A
Achat
|
SILVERSTEIN JONATHAN
Administrateur non-exécutif
|
900 000
+11.4%
2,20
1 980 000 USD
|
900 000
+11.4%
|
2,20
|
1 980 000 USD
|
|
|
2005-01-03 |
2005-01-03 |
VP
Vente planifiée
|
HANSEN JOHN DAVID
V.P. of Corporate Development
Dirigeant
|
10 200
-40.5%
3,40
34 680 USD
|
10 200
-40.5%
|
3,40
|
34 680 USD
|
|
|
2005-01-03 |
2005-01-03 |
VP
Vente planifiée
|
HANSEN JOHN DAVID
V.P. of Corporate Development
Dirigeant
|
4 800
-16.0%
3,39
16 254 USD
|
4 800
-16.0%
|
3,39
|
16 254 USD
|
|
|
2005-01-03 |
2005-01-03 |
VP
Vente planifiée
|
HANSEN JOHN DAVID
V.P. of Corporate Development
Dirigeant
|
600
-3.8%
3,42
2 052 USD
|
600
-3.8%
|
3,42
|
2 052 USD
|
|
